Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Total
Beginning balance at Dec. 31, 2021	$ 34	$ 247,059	$ (221,679)	$ 25,414
Beginning balance (in shares) at Dec. 31, 2021	34,364,679
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	368	0	368
Issuance of common stock for acquisition	$ 1	499	0	500
Issuance of common stock for acquisition (in shares)	358,367
Net loss	$ 0	0	(2,502)	(2,502)
Ending balance at Mar. 31, 2022	$ 35	247,926	(224,181)	23,780
Ending balance (in shares) at Mar. 31, 2022	34,723,046
Beginning balance at Dec. 31, 2021	$ 34	247,059	(221,679)	25,414
Beginning balance (in shares) at Dec. 31, 2021	34,364,679
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss				(5,389)
Ending balance at Sep. 30, 2022	$ 35	248,833	(227,068)	21,800
Ending balance (in shares) at Sep. 30, 2022	34,723,046
Beginning balance at Mar. 31, 2022	$ 35	247,926	(224,181)	23,780
Beginning balance (in shares) at Mar. 31, 2022	34,723,046
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	452	0	452
Net loss	0	0	(1,892)	(1,892)
Ending balance at Jun. 30, 2022	$ 35	248,378	(226,073)	22,340
Ending balance (in shares) at Jun. 30, 2022	34,723,046
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	455	0	455
Net loss	0	0	(995)	(995)
Ending balance at Sep. 30, 2022	$ 35	248,833	(227,068)	21,800
Ending balance (in shares) at Sep. 30, 2022	34,723,046
Beginning balance at Dec. 31, 2022	$ 35	249,024	(227,228)	21,831
Beginning balance (in shares) at Dec. 31, 2022	34,723,046
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	325	0	325
Issuance of restricted stock	$ 0	0	0	0
Issuance of restricted stock (in shares)	158,407
Net loss	$ 0	0	(2,835)	(2,835)
Ending balance at Mar. 31, 2023	$ 35	249,349	(230,063)	19,321
Ending balance (in shares) at Mar. 31, 2023	34,881,453
Beginning balance at Dec. 31, 2022	$ 35	249,024	(227,228)	21,831
Beginning balance (in shares) at Dec. 31, 2022	34,723,046
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss				(7,036)
Ending balance at Sep. 30, 2023	$ 35	250,422	(234,264)	16,193
Ending balance (in shares) at Sep. 30, 2023	34,913,886
Beginning balance at Mar. 31, 2023	$ 35	249,349	(230,063)	19,321
Beginning balance (in shares) at Mar. 31, 2023	34,881,453
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	352	0	352
Modification of common stock warrants	0	384	0	384
Net loss	0	0	(3,148)	(3,148)
Ending balance at Jun. 30, 2023	$ 35	250,085	(233,211)	16,909
Ending balance (in shares) at Jun. 30, 2023	34,881,453
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	337	0	337
Issuance of restricted stock	$ 0	0	0	0
Issuance of restricted stock (in shares)	32,433
Net loss	$ 0	0	(1,053)	(1,053)
Ending balance at Sep. 30, 2023	$ 35	$ 250,422	$ (234,264)	$ 16,193
Ending balance (in shares) at Sep. 30, 2023	34,913,886